Epilepsy GTx
Manufacturing · United Kingdom · 1-10 Employees
View Company Info for Free
Overview
Headquarters
Camburgh House 27 New Dover Rd, Canterbu...Website
www.epilepsygtx.coRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Feb
Mar
Apr
May
Jun
Jul
ZI Rank
1
1
1
1
1
1
About Epilepsy GTx
EpilepsyGTx is a biotech company developing innovative gene therapies to treat focal refractory epilepsy, aiming to achieve seizure freedom with a single, targeted intervention.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Epilepsy GTx your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Epilepsy GTx, which may be a good buyer, showed buying intent in Masked Content Topic
Check if Epilepsy GTx has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Epilepsy GTx has new funding data
Earning: See what the market has to say on Epilepsy GTx recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Epilepsy GTx launches new products
Congratulate Masked Content for being promoted to Masked Content at Epilepsy GTx
Click to see if Epilepsy GTx had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Check out if Epilepsy GTx is spiking on competitors!
Recommended Actions
Find VP level buyers at Epilepsy GTx
Find more new buyers
Company Profile Activity
Activity Insights
Epilepsy GTx is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Epilepsy GTx is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Epilepsy GTx.
Epilepsy GTx financials insights
Gather financial insights about Epilepsy GTx, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2024
Angel/Seed
$10M
2025
Series A
$33M
Epilepsy GTx News & Media
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Epilepsy GTx
Sign Up For FreeTo access detailed company insights
EpilepsyGTx is a biotech company developing innovative gene therapies to treat focal refractory epilepsy, aiming to achieve seizure freedom with a single, targeted intervention.... Read More
